Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Vitro Activitiy of Rezafungin in Comparison with Anidulafungin and Caspofungin against Invasive Fungal Isolates (2017 to 2022) in China

31 May 2024

Abstract excerpt

The efficacy of different echinocandins is assessed by evaluating the in vitro activity of a novel antifungal, rezafungin, against invasive fungal isolates in comparison with anidulafungin and caspofungin. Using the broth microdilution (BMD) method, the susceptibility of 1000 clinical Candida isolates (including 400 C. albicans, 200 C. glabrata, 200 C. parapsilosis, 150 C. tropicalis and 50 C. krusei) and 150...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Nematode management and characterization studies
Share to Plant Pathogens and Fungal Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38921383
DOI: 10.3390/jof10060397

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Vitro Activitiy of Rezafungin in Comparison with Anidulafungin and Caspofungin against Invasive Fungal Isolates (2017 to 2022) in ChinaPMID 38921383Read ↗

In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.Semantic proximity Read ↗

In vitro antifungal susceptibility profile and genotypic characterization of clinical Aspergillus isolates in Eastern China on behalf of Eastern China Invasive Fungi Infection Group.Semantic proximity Read ↗

Emergence of invasive candidiasis with multiple Candida species exhibiting azole and echinocandin resistanceSemantic proximity Read ↗

Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.Semantic proximity Read ↗

Epidemiological characteristics of invasive Aspergillus isolates: morphology, drug susceptibility, and mutations in azole drug targetsSemantic proximity Read ↗

Fusarium Keratitis in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Clinical FeaturesSemantic proximity Read ↗

Novel Antifungals and <em>Aspergillus</em> Section <em>Terrei</em> with Potpourri Susceptibility Profiles to Conventional AntifungalsSemantic proximity Read ↗

Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method.Semantic proximity Read ↗

Meta-Analysis of Antifungal Resistance Pattern in Aspergillus SpeciesSemantic proximity Read ↗

In Vitro Antifungal Susceptibility of Clinically Relevant Species Belonging to Aspergillus Section FlaviSemantic proximity Read ↗

Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complexSemantic proximity Read ↗

Recent Increase in the Prevalence of Fluconazole-Non-susceptible Candida tropicalis Blood Isolates in Turkey: Clinical Implication of Azole-Non-susceptible and Fluconazole Tolerant Phenotypes and GenotypingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.